Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JONATHAN L KAUFMAN

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1093819138
CMS profile
277024
Location
ATLANTA, GA

General Payments · PY2018–2024

$90,396.55

  • Reported across 119 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$4,000.63

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $2,493.00 1
Travel and Lodging $816.60 1
Food and Beverage $691.03 12

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $3,309.60 2
Janssen Biotech, Inc. $553.87 10
PFIZER INC. $137.16 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $20,373.33 42
PY2019 $32,735.37 34
PY2020 $4,749.91 3
PY2021 $383.44 4
PY2022 $9,500.00 4
PY2023 $18,653.87 18
PY2024 $4,000.63 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
GENZYME CORPORATION $2,493.00 06/03/2024 Consulting Fee Undisputed 01/23/2026 1139710511 CMS
GENZYME CORPORATION $816.60 06/03/2024 Travel and Lodging Undisputed 01/23/2026 1139710513 CMS
Janssen Biotech, Inc. $80.93 06/04/2024 Food and Beverage Undisputed 01/23/2026 1078522456 CMS
Janssen Biotech, Inc. $62.31 07/26/2024 Food and Beverage Undisputed 01/23/2026 1078525006 CMS
Janssen Biotech, Inc. $22.39 07/26/2024 Food and Beverage Undisputed 01/23/2026 1078526694 CMS
Janssen Biotech, Inc. $36.85 08/10/2024 Food and Beverage Undisputed 01/23/2026 1078524833 CMS
Janssen Biotech, Inc. $75.86 08/11/2024 Food and Beverage Undisputed 01/23/2026 1078524084 CMS
Janssen Biotech, Inc. $12.79 09/24/2024 Food and Beverage Undisputed 01/23/2026 1078523107 CMS
Janssen Biotech, Inc. $22.59 09/24/2024 Food and Beverage Undisputed 01/23/2026 1078528029 CMS
Janssen Biotech, Inc. $36.80 09/25/2024 Food and Beverage Undisputed 01/23/2026 1078523663 CMS
Janssen Biotech, Inc. $135.72 09/26/2024 Food and Beverage Undisputed 01/23/2026 1078522974 CMS
Janssen Biotech, Inc. $67.63 12/07/2024 Food and Beverage Undisputed 01/23/2026 1078524647 CMS
PFIZER INC. $34.70 07/27/2024 Food and Beverage Undisputed 01/23/2026 1131814064 CMS
PFIZER INC. $102.46 09/27/2024 Food and Beverage Undisputed 01/23/2026 1131996133 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.